Axa’s Genocea Biosciences, Inc. GNCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-72,274
| Closed | -$844K | – | 1415 |
|
|
2017
Q3 | $844K | Sell |
72,274
-984
| -1% | -$11.5K | ﹤0.01% | 995 |
|
|
2017
Q2 | $3.06M | Sell |
73,258
-2,734
| -4% | -$114K | 0.01% | 706 |
|
|
2017
Q1 | $3.7M | Buy |
75,992
+167
| +0.2% | +$8.14K | 0.02% | 654 |
|
|
2016
Q4 | $2.5M | Buy |
75,825
+1,409
| +2% | +$46.4K | 0.01% | 719 |
|
|
2016
Q3 | $3.05M | Buy |
74,416
+21
| +0% | +$860 | 0.01% | 664 |
|
|
2016
Q2 | $2.44M | Buy |
74,395
+1,023
| +1% | +$33.6K | 0.01% | 707 |
|
|
2016
Q1 | $4.54M | Hold |
73,372
| – | – | 0.02% | 585 |
|
|
2015
Q4 | $3.09M | Sell |
73,372
-1,542
| -2% | -$65K | 0.01% | 686 |
|
|
2015
Q3 | $4.11M | Buy |
74,914
+8,617
| +13% | +$472K | 0.02% | 621 |
|
|
2015
Q2 | $7.28M | Hold |
66,297
| – | – | 0.03% | 483 |
|
|
2015
Q1 | $6.29M | Buy |
66,297
+36,554
| +123% | +$3.47M | 0.03% | 523 |
|
|
2014
Q4 | $1.67M | Buy |
29,743
+8,907
| +43% | +$499K | 0.01% | 842 |
|
|
2014
Q3 | $1.51M | Hold |
20,836
| – | – | 0.01% | 820 |
|
|
2014
Q2 | $3.13M | Hold |
20,836
| – | – | 0.01% | 670 |
|
|
2014
Q1 | $3.03M | Buy |
+20,836
| New | +$3.03M | 0.01% | 651 |
|